Sphera Funds Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Sphera Funds Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-2,475	Closed	-$2.35M	–	151
2015 Q2	$2.35M	Sell	2,475 -1,275	-34%	-$1.04M	0.23%	106
2015 Q1	$2.75M	Buy	+3,750	New	+$2.82M	0.29%	89
2014 Q4	–	Sell	-118	Closed	-$47K	–	159
2014 Q3	$47K	Sell	118 -9,782	-99%	-$2.62M	0.01%	125
2014 Q2	$2.67M	Buy	+9,900	New	+$2.12M	0.66%	38

Other funds holding TTPH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Sphera Funds Management's TTPH Position: Q3 2015 in Review

Sphera Funds Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q3 2015, closing a stake of 2,475 shares — an estimated $2.35M sold.

Sphera Funds Management first reported a position in TTPH in Q2 2014 and held it in 4 quarters. The position peaked at $2.75M in Q1 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q3 2015.

Sphera Funds Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Sphera Funds Management sold 2,475 Tetraphase Pharmaceuticals, Inc. shares in Q3 2015, an estimated $2.35M.
Sphera Funds Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
Sphera Funds Management's Tetraphase Pharmaceuticals, Inc. position peaked at $2.75M in Q1 2015.
105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q3 2015.

Based on Sphera Funds Management's 13F filing for Q3 2015, filed 16 Nov 2015.